Dive into the innovative world of oncology research with The ConcertAI Podcast! ConcertAI uses artificial intelligence to revolutionize the clinical development and delivery of cancer treatments, accelerating the delivery of precision oncology to patients in need. With real-world data, clinical trial matching, patient support, and more, ConcertAI is transforming the oncology landscape. These are rapidly changing fields which require very high expertise. Tune in twice a month as we bring subject matter experts together to take a deeper dive on topics of interest and relevance.To learn more about ConcertAI please visit us at www.ConcertAI.com
In this episode, ConcertAI CEO Jeff Elton sits down with Mike Rossi, PhD - ConcertAI's Clinical Genomics Lead - to explore how real-world genomic and clinical data are transforming early-stage oncolo…
In this episode of The ConcertAI Podcast, Jeff Elton, CEO of ConcertAI, engages with Ariel Berger, Executive Director of Integrated Solutions of Evidera, part of the PPD™ clinical research business o…
In the season three opener of The ConcertAI Podcast, our guest Rory Kelleher (Senior Director, Global Head of Business Development, Life Sciences) from NVIDIA delves into the transformative role of A…
In this compelling episode of The ConcertAI Podcast, host Jeff Elton sits down with ABC's senior national correspondent, Steve Osunsami, to discuss the critical importance of prostate cancer screenin…
September marks Prostate Cancer Awareness Month, and to honor this, our latest episode of the ConcertAI Podcast features a special session with top urological cancer specialists. Host Jeff Elton welc…
Jeff Elton sits down with Dr. Robert Miller, Chief Medical and Science Officer at CancerLinQ, to unpack the integration of real-world data and AI in oncology care. Dr. Miller shares his journey from …
Jeff Elton, CEO of ConcertAI, and George Sledge, CMO of Caris Life Sciences, embark on an insightful journey through the advancements in oncology. They explore the transformative power of molecular d…
In this engaging episode, David Spetzler, President of Caris Life Sciences, and Jeff Elton, CEO of ConcertAI, discuss the transformative power of combining clinical insights and advanced AI technolog…
The second episode of The ConcertAI Podcast features Dr. Sibel Blau and Caroline Merillat, key figures in the Quality Cancer Care Alliance (QCCA) and creators of Exigent. This initiative aims to impr…
In this captivating episode of The ConcertAI Podcast, we dive deep with Jennifer Rider, a renowned cancer epidemiologist. Jennifer shares her journey from academia to the dynamic world of real-world …
We're back with The ConcertAI Podcast for Season Two!
In our first episodes, we delve deep into RWE's role in regulatory applications, such as designing registrational clinical trials and developing …
In this episode, we're thrilled to have Dr. Andy Beck, the Co-founder and CEO of PathAI, one of the leading digital pathology companies, as our guest.
Digital pathology is transforming the accessibili…
In this episode, we continue to discuss the historic challenges of running clinical trials in community settings and how AI-powered patient identification tools and semi-automated data solutions are …
A 2-Part Special with Bristol Myers Squibb on the Digitally Accelerated Clinical Trial (DACT) Model.
In part 1, we will be joined by Marissa Co, Vice President of R&D Business Insights & Analytics, a…
In this episode of the ConcertAI podcast, join our CEO Jeff Elton and Dan McSweeney, President of TeraRecon, ConcertAI's digital imaging solution, for an informative and engaging discussion. TeraReco…
Don't miss out on the latest episode of The ConcertAI Podcast featuring Catherine Richards, ConcertAI's chief data officer! Join us as we dive into the state of the field of real world data, why it's…
On this episode of The ConcertAI Podcast, we're joined by SVP of Clinical Development Technologies, Luke Dunlap. Luke and Jeff discuss the experience and transformation about how clinical trials ar…
On this episode we are joined by Dr. Warren Whyte. Dr. Whyte heads up ConcertAI’s health equity and trial diversity initiatives through the ERACE (Engaging Research to Achieve Cancer Care Equity) pro…
On our first episode, special guest Claudio D'Ambrosio covers the topic of multi-modal data in biomedical research. Multi-modal data can allow some of the deepest most advanced research questions to …